As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new ...
Discusses New Strategy and Business Plan Focused on Commercialization and Liquid Biopsy Innovation November 26, 2025 9:00 ...
OncoPrecision Corporation ("OncoPrecision"), a translational therapeutics company developing novel antibody-based cancer ...
The Brighterside of News on MSN
For the first time ever, researchers made a photon travel back in time
Shattered glass does not leap back into your hand. Smoke from a match does not gather itself and crawl back inside. In ...
November 2025 saw pivotal FDA approvals, including durvalumab for gastric cancers and pembrolizumab/enfortumab vedotin for ...
Whitehawk Therapeutics, Inc. , an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC) cancer ...
Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that its Board ...
Emerging infectious diseases, such as persistent infectious diseases that have not been controlled (i.e., HIV, dengue fever), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback